3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasms
2
Brain Neoplasms
2
Thymus Neoplasms
1
Thymoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Meningioma
1
Gliosarcoma
1
Glioblastoma
1
Central Nervous System Neoplasms
1
Cardiotoxicity
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Razoxane
4
Doxorubicin
4
Dexrazoxane
4
Vincristine
3
Etoposide
3
Radiotherapy
2
Prednisone
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Bleomycin
2
hydrocortisone hemisuccinate
1
Watchful Waiting
1
Trastuzumab
1
Proton Therapy
1
Observation
1
Mercaptopurine
1
Leucovorin
1
Ifosfamide
1
Hydrocortisone
1
Enalapril
1
Cytarabine
1
Cyclophosphamide
1
Cisplatin
1
Carvedilol
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Cardiotoxicity
×
Proton Therapy
×
Clear all
NCT04822077
2021-03-30
PROTHYM
Swedish Lung Cancer Study Group
Phase NA
Recruiting
40 enrolled